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Diagnoses of gonorrhoea are on the increase in England and a cluster of high-level 
azithromycin resistance was detected in 2015.(1, 2) Treatment options are limited and, in 
response to emerging antimicrobial resistance, treatment guidelines have changed twice 
since 2004.(3, 4) The currently recommended treatment for gonorrhoea is dual therapy with 
500mg ceftriaxone (intramuscularly) and 1g azithromycin (orally).(3) Following a diagnosis of 
gonorrhoea in general practice (GP), referral to specialist sexual health services for 
treatment, test of cure, partner notification, further STI testing and culture for antimicrobial 
susceptibility testing is recommended.(5) 
Here, we report the results of an analysis of data from GPs in England from the Clinical 
Practice Research Datalink, an anonymised extract of visits to a sample of GPs whose 
patients are representative of the UK population.(6) As the treatment guidelines were last 
updated in 2011,(3) we focus on the gonorrhoea diagnoses reported from 2011—2014. 
During this time, an estimated 4,150 gonorrhoea diagnoses were made by GPs in England, 
representing 4% of the total number of diagnoses made in all clinical settings reporting data 
(GPs and specialist sexual health clinics).  
The proportion of cases treated each year by GPs fluctuated between 50-52% (p=0729).  
Amongst those treated, the proportion given the recommended dual therapy ranged from 11- 
5% (2011—2014; p=0.488). Most cases were prescribed antibiotics no longer recommended 
for the treatment of gonorrhoea. From 2011—2014, the proportion of gonorrhoea diagnoses 
for which penicillins were prescribed fluctuated between 15-20% (p=0.729), while that of 
ciprofloxacin and azithromycin monotherapy ranged from 15-5% (p=0.166) and 7-30% 
(p=0.166), respectively. 
These findings are consistent with trends reported prior to the most recent change in 
treatment guideline in 2011.(7) While GPs diagnose fewer cases of gonorrhoea than 
specialist clinics, they make an important contribution to the management of this infection 
and there is a need to raise awareness of current treatment guidelines amongst them; this 
has recently been highlighted in a letter from England’s Chief Medical Officer to GPs.(8) 
Prompt and correct treatment of gonorrhoea is required to prevent treatment failure, onward 
transmission and the further emergence of antimicrobial resistance.  
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